Table 1 Clinical features between two groups

Age (years))

47.1 ± 10.5

48.0 ±11.3

0.272

Sex (Male/Female)

24/3

232/38

0.670

HBsAg-positive

26 (96.7%)

254 (94.1%)

0.636

Anti-HCV-positive

0

2 (1.2%)

0.654

Serum AFP (> 400 ng/ml)

16 (59.3%)

109 (40.3%)

0.058

Serum CA19-9 (> 37 U/ml)

13 (48.1%)

24 (8.8%)

< 0.001

Serum total bilirubin (umol/L)

116.4 ± 135.4

14.5 ± 7.8

< 0.001

Serum ALT (IU/L)

132.2 ± 107.9

59.6 ± 53.0

< 0.001

Serum AST (IU/L)

95.58 ± 51.5

60.1 ± 53.8

< 0.001

Serum albumin (g/L)

40.4 ± 4.92

41.8 ± 5.6

0.326

Serum GGT (IU/L)

583.1 ± 372.4

122.9 ± 134.1

< 0.001

Serum ALP (IU/L)

305.4 ± 148.0

132.2 ± 83.1

< 0.001